PaccMannRL: Designing Anticancer Drugs From Transcriptomic Data via Reinforcement Learning

The pharmaceutical industry has experienced a significant productivity decline: Less than 0.01% of drug candidates obtain market approval, with an estimated 10–15 years until market release and costs that range between one [2] to three billion dollars per drug [3].

[1]  Max Welling,et al.  Auto-Encoding Variational Bayes , 2013, ICLR.

[2]  R. Vessella,et al.  Protease‐activated receptor‐1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis , 2009, The Prostate.

[3]  R. Poojari.  Embelin – a drug of antiquity: shifting the paradigm towards modern medicine , 2014, Expert opinion on investigational drugs.

[4]  George Papadatos,et al.  The ChEMBL database in 2017 , 2016, Nucleic Acids Res..

[5]  Martin Wehling,et al.  Assessing the translatability of drug projects: what needs to be scored to predict success? , 2009, Nature Reviews Drug Discovery.

[6]  Svetlana Lazebnik,et al.  Diverse and Accurate Image Description Using a Variational Auto-Encoder with an Additive Gaussian Encoding Space , 2017, NIPS.

[7]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..

[8]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[9]  María Rodríguez Martínez,et al.  Network-based Biased Tree Ensembles (NetBiTE) for Drug Sensitivity Prediction and Drug Sensitivity Biomarker Identification in Cancer , 2018, Scientific Reports.

[10]  Alán Aspuru-Guzik,et al.  Deep learning enables rapid identification of potent DDR1 kinase inhibitors , 2019, Nature Biotechnology.

[11]  J. Scannell,et al.  Diagnosing the decline in pharmaceutical R&D efficiency , 2012, Nature Reviews Drug Discovery.

[12]  Thomas Blaschke,et al.  The rise of deep learning in drug discovery. , 2018, Drug discovery today.

[13]  Jure Leskovec,et al.  Graph Convolutional Policy Network for Goal-Directed Molecular Graph Generation , 2018, NeurIPS.

[14]  Adam A. Margolin,et al.  Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity , 2012, Nature.

[15]  R. J. Williams,et al.  Simple Statistical Gradient-Following Algorithms for Connectionist Reinforcement Learning , 2004, Machine Learning.

[16]  S. Hsu,et al.  XIAP-mediated protection of H460 lung cancer cells against cisplatin. , 2010, European journal of pharmacology.

[17]  Tomas Mikolov,et al.  Inferring Algorithmic Patterns with Stack-Augmented Recurrent Nets , 2015, NIPS.

[18]  Alán Aspuru-Guzik,et al.  Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules , 2016, ACS central science.

[19]  Olexandr Isayev,et al.  Deep reinforcement learning for de novo drug design , 2017, Science Advances.

[20]  R. Pazo-Cid,et al.  Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review , 2013, Journal of drug delivery.

[21]  Gisbert Schneider,et al.  Mind and machine in drug design , 2019, Nature Machine Intelligence.

[22]  M. Wozniak,et al.  Nitro-oxidative Stress Is Involved in Anticancer Activity of 17β-Estradiol Derivative in Neuroblastoma Cells. , 2016, Anticancer research.

[23]  Honglak Lee,et al.  Learning Structured Output Representation using Deep Conditional Generative Models , 2015, NIPS.

[24]  Sridhar Ramaswamy,et al.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..

[25]  Jannis Born,et al.  Towards Explainable Anticancer Compound Sensitivity Prediction via Multimodal Attention-based Convolutional Encoders , 2019, Molecular pharmaceutics.

[26]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[27]  Jeffrey D. Ullman,et al.  Formal languages and their relation to automata , 1969, Addison-Wesley series in computer science and information processing.

[28]  Vigneshwari Subramanian,et al.  PaccMann: Prediction of anticancer compound sensitivity with multi-modal attention-based neural networks , 2018, ArXiv.